Drug Shortage Report for CEFAZOLIN INJECTION, USP
| Report ID | 254446 |
| Drug Identification Number | 02496313 |
| Brand name | CEFAZOLIN INJECTION, USP |
| Common or Proper name | Cefazolin Injection USP 2000 mg / 100 mL |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | CEFAZOLIN |
| Strength(s) | 20MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | CA2G3508 – 12 bags/case |
| ATC code | J01DB |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | 2025-05-30 |
| Actual start date | 2025-05-30 |
| Estimated end date | 2025-09-08 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2025-04-07 |
| Company comments | Root cause is shortage of active pharmaceutical ingredient (API); product will be on 100% allocation starting April 7th and will likely be reduced later. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-04-07 | French | Compare |
| v1 | 2025-04-07 | English | Compare |
Showing 1 to 2 of 2